Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IDNA vs FTXH overlap: 16% of top holdings shared

Bottom line

How much do IDNA and FTXH overlap?

16% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 20.0% of IDNA's assets and 17.3% of FTXH's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

IDNAFTXH
Weight overlap (top 25)16%
Shared holdings5
Weight in shared holdings20.0%17.3%
Total positions6151
Expense ratio0.47%0.6%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings IDNA and FTXH have in common

Holding% of IDNA% of FTXHOverlap
Regeneron Pharmaceuticals, Inc.4.35%2.72%2.72%
Incyte Corporation4.23%2.39%2.39%
Merck & Co., Inc.3.91%7.07%3.91%
Vertex Pharmaceuticals Incorporated3.87%3.41%3.41%
Exelixis, Inc.3.65%1.72%1.72%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IDNA

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
  2. Bayer Aktiengesellschaft — 4.81%
  3. Twist Bioscience Corp — 4.79%
  4. Revolution Medicines, Inc. — 4.55%
  5. Genmab A/s — 4.23%
  6. Moderna, Inc. — 4.19%
  7. Takeda Pharmaceutical Company Limited — 4.05%
  8. Roche Holding AG — 3.85%
  9. Ipsen Sa — 3.84%
  10. BioNTech SE — 3.73%
  11. Gsk Plc — 3.63%
  12. Sanofi Sa — 3.46%
  13. IDEAYA Biosciences Inc — 3.36%
  14. Immunitybio Inc — 3.07%
  15. Arcus Biosciences, Inc. — 2.68%

Only in FTXH

  1. Eli Lilly & Company — 7.77%
  2. Abbvie Inc — 7.39%
  3. Johnson & Johnson — 6.96%
  4. Bristol-myers Squibb Company — 6.29%
  5. Biogen Inc — 3.84%
  6. Viatris Inc — 3.62%
  7. Cardinal Health Inc — 3.53%
  8. Amgen Inc — 3.18%
  9. Pfizer Inc — 2.97%
  10. Gilead Sciences Inc — 2.89%
  11. United Therapeutics Corp — 2.72%
  12. Jazz Pharmaceuticals Plc — 2.49%
  13. Illumina Inc — 1.98%
  14. Zoetis Inc — 1.87%
  15. Charles River Laboratories International Inc — 1.49%

Asset mix

Asset typeIDNAFTXH
Stocks96.0%99.9%
Cash & short-term funds10.5%0.1%
Other3.8%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryIDNAFTXH
US70.2%95.6%
DE8.5%—
FR7.8%—
JP6.0%—
CH5.4%—
DK4.2%—
IE—3.8%
GB3.7%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do IDNA and FTXH overlap?
About 16% by weight. 5 securities appear in both funds' top 25 holdings; they make up 20.0% of IDNA's assets and 17.3% of FTXH's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do IDNA and FTXH have in common?
The largest shared holdings are Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals, Inc., Incyte Corporation, Exelixis, Inc..
Should I own both IDNA and FTXH?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, IDNA or FTXH?
IDNA is broader, with 61 positions versus 51 for FTXH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.